nicotine has been researched along with deformylflustrabromine in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, X | 1 |
| Bagdas, D; Damaj, MI; Ergun, D; Jackson, A; Schulte, MK; Toma, W | 1 |
| Bagdas, D; Hamouda, AK; Imad Damaj, M; Jackson, A | 1 |
| Akinola, LS; Alkhlaif, Y; Bautista, MR; Carper, M; Chen, YC; Damaj, MI; Fowler, CD; Garai, S; Hamouda, AK; Jackson, A; Thakur, GA; Toma, WB | 1 |
| Davis, G; Decker, S; Patel, P; Suryanarayanan, A; Vahora, I; Vukovic, A | 1 |
5 other study(ies) available for nicotine and deformylflustrabromine
| Article | Year |
|---|---|
Positive allosteric modulation of α4β2 nicotinic acetylcholine receptors as a new approach to smoking reduction: evidence from a rat model of nicotine self-administration.
Topics: Allosteric Regulation; Animals; Azetidines; Dose-Response Relationship, Drug; Galantamine; Hydrocarbons, Brominated; Indole Alkaloids; Male; Nicotine; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Reinforcement Schedule; Self Administration; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder | 2013 |
Allosteric modulation of α4β2* nicotinic acetylcholine receptors: Desformylflustrabromine potentiates antiallodynic response of nicotine in a mouse model of neuropathic pain.
Topics: Allosteric Regulation; Animals; Disease Models, Animal; Hydrocarbons, Brominated; Indole Alkaloids; Male; Mice; Neuralgia; Nicotine; Nicotinic Agonists; Receptors, Nicotinic | 2018 |
Reversal of Nicotine Withdrawal Signs Through Positive Allosteric Modulation of α4β2 Nicotinic Acetylcholine Receptors in Male Mice.
Topics: Allosteric Regulation; Animals; Hydrocarbons, Brominated; Indole Alkaloids; Infusion Pumps, Implantable; Male; Mice; Mice, Inbred ICR; Nicotine; Nicotinic Agonists; Receptors, Nicotinic; Smoking Cessation; Substance Withdrawal Syndrome; Varenicline | 2018 |
Potentiation of (α4)2(β2)3, but not (α4)3(β2)2, nicotinic acetylcholine receptors reduces nicotine self-administration and withdrawal symptoms.
Topics: Allosteric Regulation; Animals; Behavior, Animal; Hydrocarbons, Brominated; Indole Alkaloids; Isoxazoles; Mice; Nicotine; Nicotinic Agonists; Protein Isoforms; Pyrazoles; Receptors, Nicotinic; Self Administration; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2021 |
Desformylflustrabromine (dFBr), a positive allosteric modulator of α4β2 nicotinic acetylcholine receptors decreases voluntary ethanol consumption and preference in male and female Sprague-Dawley rats.
Topics: Animals; Ethanol; Female; Hydrocarbons, Brominated; Indole Alkaloids; Male; Nicotine; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic | 2022 |